Pfizer Total Liabilities 2012-2026 | PFE

Pfizer total liabilities for the quarter ending March 31, 2026 were $115.635B, a 8.89% decline year-over-year.

  • Pfizer total liabilities for 2024 were $124.899B, a 8.97% decline from 2023.
  • Pfizer total liabilities for 2023 were $137.213B, a 35.47% increase from 2022.
  • Pfizer total liabilities for 2022 were $101.288B, a 2.62% decline from 2021.

Pfizer Total Liabilities 2012-2026 | PFE

  • Pfizer total liabilities for 2024 were $124.899B, a 8.97% decline from 2023.
  • Pfizer total liabilities for 2023 were $137.213B, a 35.47% increase from 2022.
  • Pfizer total liabilities for 2022 were $101.288B, a 2.62% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B